Janssen Biotech, Inc.

TALVEY

Manufacturer:

Janssen Biotech, Inc.

Talvey HCPCS:

J3055

HCPCS Code Descriptor:

Injection, talquetamab-tgvs, 0.25 mg

Category:

J Code

Talvey NDCs:

57894-0470-01, 57894-0469-01

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Not Found

Route of Administration:

Subcutaneous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Talvey:

TALVEY is aligned to the J Code: J3055. TALVEY is an Oncology drug produced by Janssen Biotech, Inc. and administered via the Subcutaneous route of administration.

ACCESS PRICING AND MORE BY REGISTERING

J3055 Added Date:

4/1/24

J3055 Effective Date:

4/1/24

J3055 Deactive Date:

HCPCS Active

Talvey billing and coding information can be found through Janssen Biotech, Inc. at the link below:
Talvey patient assistance information can be found through Janssen Biotech, Inc. at the URL: https://www.talvey.com/support-and-resources/
TALVEY prescribing information can be found at the link below:
Information regarding TALVEY’s potential side effects can be found at MedlinePlus